Literature DB >> 7361900

Intravenous indomethacin and aspirin reduce basal gastric mucosal blood flow in dogs.

G L Kauffman, D Aures, M I Grossman.   

Abstract

The effect of two known inhibitors of prostaglandin synthesis, indomethacin and aspirin, on blood flow was studied in six Heidenhain pouch and three antral pouch dogs. The unstimulated gastric mucosa was bathed with 0.15 M HCl and clearance of [14C]-aminopyrine was used as an index of changes in mucosal blood flow. [14C]aminopyrine clearance was measured during three 15-min predrug periods and five 15 min-postdrug periods. Either indomethacin (10 mg . kg-1), aspirin (100 mg . kg-1), or 0.15 M NaCl were given intravenously as a bolus. Indomethacin reduced mucosal blood flow in the Heidenhain pouch 52% (P less than 0.05) and in the antral pouch 52% (P less than 0.05). Aspirin reduced Heidenhain pouch mucosal blood flow 31% (P less than 0.05). Indomethacin caused no significant change in electrical potential difference or in net flux of H+ or Na+ in Heidenhain pouches. Indomethacin (10 mg . kg-1 iv) produced no change in mean arterial pressure. We conclude that indomethacin and aspirin reduce unstimulated gastric mucosal blood flow, suggesting that endogenous prostaglandin may contribute to its maintenance.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7361900     DOI: 10.1152/ajpgi.1980.238.2.G131

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

Review 1.  Non-steroidal anti-inflammatory drug-induced gastropathy. Mechanisms and management.

Authors:  S Szabo; W F Spill; K D Rainsford
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr

2.  Gastric motility is an important factor in the pathogenesis of indomethacin-induced gastric mucosal lesions in rats.

Authors:  S Ueki; K Takeuchi; S Okabe
Journal:  Dig Dis Sci       Date:  1988-02       Impact factor: 3.199

3.  Anti-inflammatory drugs and upper gastrointestinal ulcer perforation.

Authors:  D S Collier; J A Pain
Journal:  Clin Rheumatol       Date:  1985-12       Impact factor: 2.980

4.  The gastric mucosal barrier. Component control.

Authors:  G L Kauffman
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

5.  Cyclooxygenase inhibition with indomethacin increases human duodenal mucosal response to prostaglandin E1.

Authors:  D L Hogan; M A Ballesteros; M A Koss; J I Isenberg
Journal:  Dig Dis Sci       Date:  1989-12       Impact factor: 3.199

6.  Chemical gastritis and Helicobacter pylori related gastritis in patients receiving non-steroidal anti-inflammatory drugs: comparison and correlation with peptic ulceration.

Authors:  A S Taha; I Nakshabendi; F D Lee; R D Sturrock; R I Russell
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

7.  Non-steroidal anti-inflammatory drugs and peptic ulcer perforation.

Authors:  D S Collier; J A Pain
Journal:  Gut       Date:  1985-04       Impact factor: 23.059

8.  The potentiation of taurocholate-induced rat gastric erosions following parenteral administration of cyclo-oxygenase inhibitors.

Authors:  B J Whittle
Journal:  Br J Pharmacol       Date:  1983-11       Impact factor: 8.739

9.  Cholecystokinin is a potent protective agent against alcohol-induced gastric injury in the rat. Role of endogenous prostaglandins.

Authors:  D W Mercer; J M Cross; J C Barreto; N H Strobel; D H Russell; T A Miller
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

10.  Indomethacin decreases resistance of gastric barrier to disruption by alcohol.

Authors:  T A Miller; J M Henagan
Journal:  Dig Dis Sci       Date:  1984-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.